Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

The VISTA trial is evaluating and comparing 2 dose levels of laru-zova with an untreated control group for the treatment of X ...

Healthcare professionals must stop supplying the affected batch, quarantine stock, and return it to suppliers.

In honor of Ophthalmology Times’ 50th anniversary, anterior segment surgeons attending ASCRS 2025 weigh in on the innovations ...